Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127448851 | 12744885 | 1 | I | 20160823 | 20160915 | 20160915 | EXP | US-ROCHE-1829702 | ROCHE | 61.00 | YR | F | Y | 64.00000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127448851 | 12744885 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 600 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 10 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 11 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 13 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 14 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 15 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 16 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1200 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 17 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 600 | MG | SOLUTION FOR INFUSION | |||||||
127448851 | 12744885 | 18 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 75 | MG | ||||||||
127448851 | 12744885 | 19 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 100 | MG | ||||||||
127448851 | 12744885 | 20 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 100 | MG | ||||||||
127448851 | 12744885 | 21 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 100 | MG | ||||||||
127448851 | 12744885 | 22 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 100 | MG | ||||||||
127448851 | 12744885 | 23 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 24 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 80 | MG | ||||||||
127448851 | 12744885 | 25 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 45 | MG | ||||||||
127448851 | 12744885 | 26 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 27 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 28 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 29 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 30 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 31 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 32 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 33 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 60 | MG | ||||||||
127448851 | 12744885 | 34 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 15 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127448851 | 12744885 | 1 | Malignant neoplasm of islets of Langerhans |
127448851 | 12744885 | 18 | Malignant neoplasm of islets of Langerhans |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127448851 | 12744885 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127448851 | 12744885 | Alanine aminotransferase increased | |
127448851 | 12744885 | Aspartate aminotransferase increased | |
127448851 | 12744885 | Blood alkaline phosphatase increased | |
127448851 | 12744885 | Blood bilirubin increased | |
127448851 | 12744885 | Hyperglycaemia | |
127448851 | 12744885 | Lymphocyte count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127448851 | 12744885 | 1 | 20100903 | 0 | ||
127448851 | 12744885 | 2 | 20101001 | 0 | ||
127448851 | 12744885 | 3 | 20101029 | 0 | ||
127448851 | 12744885 | 4 | 20101126 | 0 | ||
127448851 | 12744885 | 5 | 20101222 | 0 | ||
127448851 | 12744885 | 6 | 20110119 | 0 | ||
127448851 | 12744885 | 7 | 20110218 | 0 | ||
127448851 | 12744885 | 8 | 20110318 | 0 | ||
127448851 | 12744885 | 9 | 20110415 | 0 | ||
127448851 | 12744885 | 10 | 20110513 | 0 | ||
127448851 | 12744885 | 11 | 20110610 | 0 | ||
127448851 | 12744885 | 12 | 20110708 | 0 | ||
127448851 | 12744885 | 13 | 20110805 | 0 | ||
127448851 | 12744885 | 14 | 20110902 | 0 | ||
127448851 | 12744885 | 15 | 20110930 | 0 | ||
127448851 | 12744885 | 16 | 20111028 | 0 | ||
127448851 | 12744885 | 17 | 20111209 | 0 | ||
127448851 | 12744885 | 18 | 20100903 | 0 | ||
127448851 | 12744885 | 19 | 20101001 | 0 | ||
127448851 | 12744885 | 20 | 20101029 | 0 | ||
127448851 | 12744885 | 21 | 20101126 | 0 | ||
127448851 | 12744885 | 22 | 20101222 | 0 | ||
127448851 | 12744885 | 23 | 20110119 | 0 | ||
127448851 | 12744885 | 24 | 20110218 | 0 | ||
127448851 | 12744885 | 25 | 20110318 | 0 | ||
127448851 | 12744885 | 26 | 20110415 | 0 | ||
127448851 | 12744885 | 27 | 20110513 | 0 | ||
127448851 | 12744885 | 28 | 20110610 | 0 | ||
127448851 | 12744885 | 29 | 20110708 | 0 | ||
127448851 | 12744885 | 30 | 20110805 | 0 | ||
127448851 | 12744885 | 31 | 20110902 | 0 | ||
127448851 | 12744885 | 32 | 20110930 | 0 | ||
127448851 | 12744885 | 33 | 20111028 | 0 | ||
127448851 | 12744885 | 34 | 20111209 | 0 |